Latest filing published 01 Jun 2010 for Oncternal Therapeutics, Inc., €44k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gregory A. Deener: trading record in brief
All filings by Gregory A. Deener on record concern Oncternal Therapeutics, Inc. The record holds 6 filings, for trades running from 20 December 2006 to 27 May 2010.
Both buying and selling appear: 3 purchases worth €95k, against 3 sales worth €58k. The net balance comes to €37k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2010, the count stands at 2 purchases and no sales.
Half of the purchases are above €44k and half below.
The newest entry dates from 14 June 2010: an open-market purchase of €44k, in Oncternal Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Gregory A. Deener
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,000 shares@ US$2.01Common StockSEC:0001209191-10-031219:0Canonical exit: 25 Aug 2010 (T+90)
- 825 shares@ US$9.97Common StockSEC:0001209191-09-005259:0Canonical exit: 27 Apr 2009 (T+90)
- 1,000 shares@ US$22.16Common StockSEC:0001209191-07-013941:0
- 2,000 shares@ US$18.05Common StockSEC:0001209191-06-066596:0
- 1,000 shares@ US$18.07Common StockSEC:0001209191-06-066596:1
5 of 5 declarations
